Industry Speaker Series: The “Art” (Hewig) of Leadership, Discomfort, and Balance

Join us for our first in-person Industry Talk of the semester, featuring Art Hewig. You can register here.

Art Hewig is the Vice President of Biologics Process Development at Gilead Sciences in Oceanside, CA, where he currently leads a >150 member organization of scientists and engineers to deliver early stage, late stage, and life cycle management assets of Gilead’s multi-modality biologics portfolio and advance the development of innovative technologies. He is responsible for overseeing the development of Gilead’s diverse biologics portfolio from the research collaboration stage to commercialization. This includes Cell Line Development, Upstream Process Development, Downstream Process Development, Formulation/Drug Product Development, and Analytical Operations including Quality Control. Previous to this role, Hewig worked at Amgen for 19 years in bioprocess development across all phases of commercialization. He has a proven track record of developing robust drug substance processes for a wide range of modalities including mAbs, biosimilars, BiTEs, bispecifics, and siRNA programs, and a demonstrated ability to rapidly learn and adapt to the changing needs of the multi-modality pipeline, including the establishment of modular platforms. He has also driven innovation and technology efforts to transform biomanufacturing strategies aligned with broader strategic goals. Hewig received his doctorate in Chemical Engineering from Carnegie Mellon University and BS/MS in Chemical Engineering from Rensselaer Polytechnic Institute.

Please come prepared to engage! 

Thank you to our sponsor Wilson Sonsini for providing lunch to the first 40 attendees. 

The KGI Industry Speaker Series is sponsored by Wilson Sonsini. 

_{About Wilson Sonsini Goodrich & Rosati: 
For more than 60 years, Wilson Sonsini’s services and legal disciplines have focused on serving the principal challenges faced by the management and boards of directors of business enterprises. The firm is nationally recognized as a leading provider to growing and established clients seeking legal counsel to complete sophisticated corporate and technology transactions; manage governance and enterprise-scale matters; assist with intellectual property development, protection, and IP-driven transactions; represent them in contested disputes; and/or advise them on antitrust or other regulatory matters. With deep roots in Silicon Valley, Wilson Sonsini has offices in Austin; Beijing; Boston; Brussels; Hong Kong; London; Los Angeles; New York; Palo Alto; San Diego; San Francisco; Seattle; Shanghai; Washington, D.C.; and Wilmington, DE. For more information, please visit www.wsgr.com.}